A Study of Oral Ibogaine in Opioid Withdrawal

NCT05029401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Opiate Withdrawal Syndrome

Interventions

DRUG: DMX-1002
DRUG: Placebo

Sponsor

atai Therapeutics, Inc.

Collaborators

[object Object]
[object Object]
[object Object]